PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 206 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $130,000 | +8.3% | 41,154 | 0.0% | 0.00% | – |
| Q2 2020 | $120,000 | -28.1% | 41,154 | -30.6% | 0.00% | – |
| Q1 2020 | $167,000 | -13.5% | 59,329 | 0.0% | 0.00% | – |
| Q4 2019 | $193,000 | +62.2% | 59,329 | +8.0% | 0.00% | – |
| Q3 2019 | $119,000 | -37.0% | 54,929 | -8.6% | 0.00% | – |
| Q2 2019 | $189,000 | -15.2% | 60,066 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $223,000 | +19.9% | 60,066 | -6.3% | 0.00% | – |
| Q4 2018 | $186,000 | +10.1% | 64,117 | 0.0% | 0.00% | – |
| Q3 2018 | $169,000 | +12.7% | 64,117 | 0.0% | 0.00% | – |
| Q2 2018 | $150,000 | -28.6% | 64,117 | -10.3% | 0.00% | – |
| Q1 2018 | $210,000 | 0.0% | 71,469 | -6.7% | 0.00% | – |
| Q4 2017 | $210,000 | -25.0% | 76,599 | -7.3% | 0.00% | -100.0% |
| Q3 2017 | $280,000 | +37.3% | 82,612 | 0.0% | 0.00% | – |
| Q2 2017 | $204,000 | +25.9% | 82,612 | +15.7% | 0.00% | – |
| Q1 2017 | $162,000 | +7.3% | 71,377 | 0.0% | 0.00% | – |
| Q4 2016 | $151,000 | -36.8% | 71,377 | 0.0% | 0.00% | – |
| Q3 2016 | $239,000 | +6.7% | 71,377 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $224,000 | -5.9% | 71,377 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $238,000 | -5.9% | 71,377 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $253,000 | -29.5% | 71,377 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $359,000 | -35.9% | 71,377 | -18.0% | 0.00% | 0.0% |
| Q2 2015 | $560,000 | -13.2% | 87,037 | -5.0% | 0.00% | 0.0% |
| Q1 2015 | $645,000 | -8.6% | 91,630 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $706,000 | +3.2% | 91,630 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $684,000 | -22.9% | 91,630 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $887,000 | +16.6% | 91,630 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $761,000 | -1.6% | 91,630 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $773,000 | +5.9% | 91,630 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $730,000 | +3.3% | 91,630 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $707,000 | – | 91,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KESTREL INVESTMENT MANAGEMENT CORP | 1,634,000 | $4,804,000 | 1.81% |
| SMH CAPITAL ADVISORS INC | 80,722 | $237,000 | 0.37% |
| Matarin Capital Management, LLC | 1,126,641 | $3,312,325,000 | 0.25% |
| Hillsdale Investment Management Inc. | 337,800 | $993,000 | 0.14% |
| Zebra Capital Management LLC | 115,431 | $339,000 | 0.12% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,789,702 | $14,082,000 | 0.08% |
| Fortis Advisors, LLC | 45,602 | $134,000 | 0.07% |
| Municipal Employees' Retirement System of Michigan | 500,080 | $1,470,000 | 0.07% |
| RBF Capital, LLC | 173,090 | $508,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 392,276 | $1,153,000 | 0.06% |